GUILLERMO
VELASCO DÍEZ
Profesor titular de universidad
Hospital Clínico San Carlos de Madrid
Madrid, EspañaPublicaciones en colaboración con investigadores/as de Hospital Clínico San Carlos de Madrid (11)
2024
-
Immune checkpoints between epithelial-mesenchymal transition and autophagy: A conflicting triangle
Cancer Letters, Vol. 585
-
POTEE promotes breast cancer cell malignancy by inducing invadopodia formation through the activation of SUMOylated Rac1
Molecular Oncology, Vol. 18, Núm. 3, pp. 620-640
-
Transcending frontiers in prostate cancer: the role of oncometabolites on epigenetic regulation, CSCs, and tumor microenvironment to identify new therapeutic strategies
Cell Communication and Signaling, Vol. 22, Núm. 1
2023
-
Mapping Immune Correlates and Surfaceome Genes in BRAF Mutated Colorectal Cancers
Current Oncology, Vol. 30, Núm. 3, pp. 2569-2581
-
Pseudokinases, Tribbles Proteins and Cancer
Cancers
2022
2021
2012
-
Towards the use of cannabinoids as antitumour agents
Nature Reviews Cancer, Vol. 12, Núm. 6, pp. 436-444
2011
-
A combined preclinical therapy of cannabinoids and temozolomide against glioma
Molecular Cancer Therapeutics, Vol. 10, Núm. 1, pp. 90-103
-
Stimulation of ALK by the growth factor midkine renders glioma cells resistant to autophagy-mediated cell death
Autophagy, Vol. 7, Núm. 9, pp. 1071-1073
-
Stimulation of the midkine/ALK axis renders glioma cells resistant to cannabinoid antitumoral action
Cell Death and Differentiation, Vol. 18, Núm. 6, pp. 959-973